Disease activity assessment in large vessel vasculitis
Abstract Views: 1813
PDF: 1024
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Similar Articles
- S. Barsotti, E. Cioffi, A. Tripoli, A. Tavoni, A. d’Ascanio, M. Mosca, R. Neri, The use of rituximab in idiopathic inflammatory myopathies: description of a monocentric cohort and review of the literature , Reumatismo: Vol. 70 No. 2 (2018)
- C.S.R. Araujo, A.M. dos Santos, P.A. Olivo Pallo, R.M.R. Pereira, S.K. Shinjo, Is there a reliable association between patient-reported limb claudication and vascular imaging methods in Takayasu arteritis? , Reumatismo: Vol. 72 No. 2 (2020)
- A. Fayed, M.M. El Menyawi, M. Ghanema, O. Shaker, R. Elgohary, Measurement of serum interferon alpha in Egyptian patients with systemic lupus erythematosus and evaluation of its effect on disease activity: a case-control study , Reumatismo: Vol. 72 No. 3 (2020)
- C. Garufi, S. Mancuso, F. Ceccarelli, L. Caruso, C. Alessandri, M. Di Franco, R. Priori, V. Riccieri, R. Scrivo, S. Truglia, F. Conti, F.R. Spinelli, PASSing to the patient side: early achieving of an acceptable symptom state in patients with rheumatoid arthritis treated with Janus kinase inhibitors , Reumatismo: Early Access
- M. Manara, L. Arcarese, G. Bianchi, V. Corbelli, O. Epis, R. Laurenti, A. Migliore, M. Muratore, A. Roncaglione, M. Rossini, M. Savo, L. Sinigaglia, The impact on disability of initial treatment with methotrexate in patients with rheumatoid arthritis: results from the MARI study , Reumatismo: Vol. 68 No. 4 (2016)
- M. Rossini, S. Adami, F. Bertoldo, D. Diacinti, D. Gatti, S. Giannini, A. Giusti, N. Malavolta, S. Minisola, G. Osella, M. Pedrazzoni, L. Sinigaglia, O. Viapiana, G. C. Isaia, Guidelines for the diagnosis, prevention and management of osteoporosis , Reumatismo: Vol. 68 No. 1 (2016)
- M. Bellan, D. Soddu, E. Zecca, A. Croce, R. Bonometti, R. Pedrazzoli, D. Sola, C. Rigamonti, L.M. Castello, G.C. Avanzi, M. Pirisi, P.P. Sainaghi, Association between red cell distribution width and response to methotrexate in rheumatoid arthritis , Reumatismo: Vol. 72 No. 1 (2020)
- E. Lubrano, R. Scarpa, Psoriatic arthritis: treatment strategies using anti-inflammatory drugs and classical DMARDs , Reumatismo: Vol. 64 No. 2 (2012)
- M. Lorenzin, A. Ortolan, P. Frallonardo, S. Vio, C. Lacognata, F. Oliviero, L. Punzi, R. Ramonda, Spine and sacroiliac joints on magnetic resonance imaging in patients with early axial spondyloarthritis: prevalence of lesions and association with clinical and disease activity indices from the Italian group of the SPACE study , Reumatismo: Vol. 68 No. 2 (2016)
- S. D'Angelo, C. Palazzi, I. Olivieri, Psoriatic arthritis: treatment strategies using biologic agents , Reumatismo: Vol. 64 No. 2 (2012)
<< < 3 4 5 6 7 8 9 10 11 12 > >>
You may also start an advanced similarity search for this article.